Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
The present study showed that immunotherapies were commonly used and resulted in fewer treatment discontinuations in comparison to other systemic chemotherapies. These results support the use of immunotherapies in this patient population.
The rich immune infiltrate within Head & Neck squamous cell carcinoma (HNSCC) designates them as prime candidates for Cancer Immunotherapy / Immuno-Oncology. Immunotherapy as a single-agent treatment has typically resulted in either short-lived responses or long-lasting responses in only a small group of patients.
Multiple randomized phase III trials comparing anti-PD(L)-antibodies …